PMID- 32002148 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20200928 IS - 2000-9666 (Print) IS - 2000-9666 (Electronic) IS - 2000-9666 (Linking) VI - 9 IP - 6 DP - 2019 TI - Clinical features of angioedema induced by renin-angiotensin-aldosterone system inhibition: a retrospective analysis of 84 patients. PG - 453-459 LID - 10.1080/20009666.2019.1698259 [doi] AB - Background and objectives: Bradykinin-mediated angioedema (AE) induced by antihypertensive drugs primarily affect the head and neck region and may occur even after several years of uneventful treatment. Many facts about the clinical course remain unknown. Diagnosis is not easy, as the clinical appearance resembles allergic AE. No specific diagnostic markers are known and no officially approved treatment is currently available. Methods: All patients who presented to the ORL department between 2010 and 2016 with acute AE were included. Those with a history of renin-angiotensin-aldosterone system (RAAS) blocker intake were defined as RAE and their pathophysiological characteristics and clinical course of the disease were analyzed. Results: A total of 84 patients (median age of 71 years) with RAE was identified. The majority (80%) was on ACE inhibition. The oral cavity was most often affected. Nearly 60% were medicated for more than 1 year before AE occurred. RAE occurred more often during the morning hours. The necessity for emergency intubation and/or tracheostomy was nine times higher in patients with acute RAE compared to patients with AE due to other reasons. Conclusions: Event-free, long-term therapy with an RAAS blocker before the first development of edema does not exclude RAE. RAE is associated with an increased risk for emergency airway management. Abbreviations ACE: Angiotensin Converting Enzyme; ACEi AE: ACE inhibitor-induced angioedema; AE: Angioedema; ARB: Angiotensin II receptor 1 blocker; C1 INH: C1 Inhibitor; CI: Confidence Interval; CRP: C-reactive protein; DPP IV: Dipeptidyl peptidase IV; ENT: Ear, Nose and Throat; HAE: Hereditary Angioedema; ICD 10: International Statistical Classification of Diseases and Related Health Problems, 10th Edition; OR: Odds Ratio; ORL: Otorhinolaryngology; RAAS: Renin-Angiotensin-Aldosterone System; RAE: RAAS-blocker-induced angioedema. CI - (c) 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group on behalf of Greater Baltimore Medical Center. FAU - Pfaue, Anja AU - Pfaue A AD - Department for Otorhinolaryngology, Head and Neck Surgery, Ulm University Hospital, Ulm, Germany. FAU - Schuler, Patrick J AU - Schuler PJ AD - Department for Otorhinolaryngology, Head and Neck Surgery, Ulm University Hospital, Ulm, Germany. FAU - Mayer, Benjamin AU - Mayer B AD - Institute of Epidemiology and Medical Biometry, Ulm University, Ulm, Germany. FAU - Hoffmann, Thomas K AU - Hoffmann TK AD - Department for Otorhinolaryngology, Head and Neck Surgery, Ulm University Hospital, Ulm, Germany. FAU - Greve, Jens AU - Greve J AD - Department for Otorhinolaryngology, Head and Neck Surgery, Ulm University Hospital, Ulm, Germany. FAU - Hahn, Janina AU - Hahn J AUID- ORCID: 0000-0001-7641-7118 AD - Department for Otorhinolaryngology, Head and Neck Surgery, Ulm University Hospital, Ulm, Germany. LA - eng PT - Journal Article DEP - 20191214 PL - United States TA - J Community Hosp Intern Med Perspect JT - Journal of community hospital internal medicine perspectives JID - 101601396 PMC - PMC6968333 OTO - NOTNLM OT - ACE inhibitor OT - Angioedema OT - RAAS OT - bradykinin EDAT- 2020/02/01 06:00 MHDA- 2020/02/01 06:01 PMCR- 2019/12/14 CRDT- 2020/02/01 06:00 PHST- 2019/09/25 00:00 [received] PHST- 2019/11/08 00:00 [accepted] PHST- 2020/02/01 06:00 [entrez] PHST- 2020/02/01 06:00 [pubmed] PHST- 2020/02/01 06:01 [medline] PHST- 2019/12/14 00:00 [pmc-release] AID - 1698259 [pii] AID - 10.1080/20009666.2019.1698259 [doi] PST - epublish SO - J Community Hosp Intern Med Perspect. 2019 Dec 14;9(6):453-459. doi: 10.1080/20009666.2019.1698259. eCollection 2019.